Stefania Castrezzati Selected Research

Stefania Castrezzati Research Topics

3	Inflammation (Inflammations) 01/2023 - 01/2013
3	Parkinson Disease (Parkinson's Disease) 01/2023 - 07/2015
3	Obesity 10/2021 - 10/2013
2	Facial Pain (Myofacial Pain) 08/2023 - 08/2023
2	Gliosis 01/2023 - 01/2023
2	Neuroinflammatory Diseases 01/2023 - 01/2023
1	Neuralgia (Stump Neuralgia) 08/2023
1	Pain (Aches) 08/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Metabolic Diseases (Metabolic Disease) 10/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2015
1	Nerve Degeneration 07/2015
1	Body Weight (Weight, Body) 10/2013
1	Reperfusion Injury 01/2013
1	Atherosclerosis 01/2013
1	Hypertension (High Blood Pressure) 01/2013

4	MelatoninIBA 08/2023 - 01/2013
2	Leucine (L-Leucine)FDA Link 01/2023 - 01/2023
2	Phosphotransferases (Kinase)IBA 01/2023 - 01/2023
1	Glutamic Acid (Glutamate)FDA Link 08/2023
1	AntioxidantsIBA 08/2023
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2023
1	SolutionsIBA 08/2023
1	Nerve Growth Factors (Neurotrophins)IBA 08/2023
1	3- (4- (morpholin- 4- yl)- 7H- pyrrolo(2,3- d)pyrimidin- 5- yl)benzonitrileIBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	Sodium-Glucose Transport ProteinsIBA 10/2021
1	SodiumIBA 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	AdipokinesIBA 10/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2015
1	CytokinesIBA 10/2015
1	Synapsins (Synapsin I)IBA 07/2015
1	SynucleinsIBA 07/2015
1	Drinking WaterIBA 10/2013
1	Ethanol (Ethyl Alcohol)IBA 10/2013
1	Vasoconstrictor AgentsIBA 01/2013
1	Nicotine FDA Link 01/2013
1	Free RadicalsIBA 01/2013